Zevra Therapeutics
Price & Volume
Stats
See more52W Range | $6.19-$13.16 |
Market Cap | $505.5M |
Shares Short | 4M |
Financials
See moreRevenue (12 Mos) | $84.3M |
Revenue Growth (YoY) | 605.4% |
Gross Profit (12 Mos) | $68M |
Diluted EPS | $0.47 |
News
See moreYahoo Finance • last month
Zevra Therapeutics Presents Positive New Real-World Data on MIPLYFFA® in Patients with Neimann-Pick Disease Type C (NPC) at the 22nd Annual WORLDSymposium™
Yahoo Finance • last month
Zevra Therapeutics to Ring Nasdaq Stock Market Opening Bell on Monday, February 9, 2026
Yahoo Finance • 3 months ago
Zevra Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance • 3 months ago
Zevra Therapeutics, Inc. Appoints Alicia Secor to Board of Directors; Announces Retirement of Wendy Dixon, PhD
About
CEO | Mr. Neil F. McFarlane |
Address | 1180 Celebration Boulevard, Celebration, FL, United States, 34747 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 59 |
